▲ Peaking
Health
CRISPR makes prostate cancer vulnerable to immunotherapy
Researchers are using CRISPR gene editing to make 'immune-cold' prostate tumors visible to immunotherapy, potentially overcoming cancer's stealth mechanisms.
Gene Editing
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades
Exclusive: A couple paid more than $800,000 for a gene-editing therapy for their daughter. She died, and it wasn’t made public
A secret death in a Chinese gene-editing trial involving a six-year-old girl and an $800,000 payment has sparked a global ethics crisis.
◼ Archived
Business
🔮 fades
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
Scribe Therapeutics seeks $75 million in an IPO, testing market appetite for early-stage biotech.